WWolfe Research RRivian · RIVN

Wolfe Downgrades Rivian to Underperform

Jan 12, 2026· 1 min read· Reproduced verbatim
Rating
Sell
Price target
$16
Previous
Implied downside
-17%

Wolfe Research analyst Emmanuel Rosner downgraded on January 12, 2026, Rivian from ‘Peerperform’ to ‘Underperform’ with a price target of $16.

RIVN to UP: Risk/Reward challenging at current levels.

While the near-term and long-term fundamental setup for RIVN have deteriorated, enthusiasm around RIVN’s Autonomy platform has driven a sharp rise in the shares.

 

But as look to 2026, Street ests appear too high (we est EBITDA loss of $2.1 bn vs Cons of -$1.76 bn). FCF burn is likely to step-up towards ~$4+ bn, with higher Capex / Opex and WC headwinds.

 

And we see potential downside risks to near-term R2 demand, with volumes likely heavily weighted to Q426.

 

Meanwhile, and unlike TSLA, we do not expect many Autonomy / AI-related potential catalysts, with key launches set for late-2026.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.